Link to Dr. Guang-Shing Cheng's NCBI Bibliography

Turner J, He Q, Baker K, Chung L, Lazarevic-Fogelquist A, Bethune D, Hubbard J, Guerriero M, Sheshadri A, Syrjala KL, Martin PJ, Boeckh M, Lee SJ, Gooley T, Flowers ME, Cheng GS. Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease. Transplant Cell Ther. 2021 Jul;27(7):616.e1-616.e6. doi: 10.1016/j.jtct.2021.03.024. Epub 2021 Mar 26. PubMed PMID: 33781975; PubMed Central PMCID: PMC8423348.

Matthaiou EI, Sharifi H, O'Donnell C, Chiu W, Owyang C, Chatterjee P, Turk I, Johnston L, Brondstetter T, Morris K, Cheng GS, Hsu JL. The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial. Bone Marrow Transplant. 2022 Aug;57(8):1319-1326. doi: 10.1038/s41409-022-01716-4. Epub 2022 May 31. PubMed PMID: 35641662; PubMed Central PMCID: PMC9357121.

Sheshadri A, Alousi A, Bashoura L, Stolar K, Baghaie S, Arain MH, Noor L, Balagani A, Jain A, Blanco D, Ortiz A, Peterson SK, Langhals R, Taylor M, Stenzler A, Mehta RS, Popat UR, Hosing C, Rondon G, Shen F, Li L, Cheng GS, Ost DE, Champlin RE, Dickey BF. Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients. Ann Am Thorac Soc. 2020 Oct;17(10):1329-1333. doi: 10.1513/AnnalsATS.202005-434RL. PubMed PMID: 32614241; PubMed Central PMCID: PMC7640620.

Cheng GS, Selwa KE, Hatt C, Ram S, Fortuna AB, Guerriero M, Himelhoch B, McAree D, Hoffman TC, Brisson J, Nazareno R, Bloye K, Johnson TD, Remberger M, Mattsson J, Vummidi D, Kazerooni EE, Lama VN, Galban S, Boeckh M, Yanik GA, Galban CJ. Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Am J Transplant. 2020 Aug;20(8):2198-2205. doi: 10.1111/ajt.15814. Epub 2020 Mar 6. PubMed PMID: 32034974; PubMed Central PMCID: PMC7395854.

Cheng GS, Bondeelle L, Gooley T, He Q, Jamani K, Krakow EF, Flowers MED, de Latour RP, Michonneau D, Socié G, Chien JW, Chevret S, Bergeron A. Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020 Feb;26(2):392-400. doi: 10.1016/j.bbmt.2019.10.025. Epub 2019 Nov 1. PubMed PMID: 31682980; PubMed Central PMCID: PMC7430235.

Wolff D, Radojcic V, Lafyatis R, Cinar R, Rosenstein RK, Cowen EW, Cheng GS, Sheshadri A, Bergeron A, Williams KM, Todd JL, Teshima T, Cuvelier GDE, Holler E, McCurdy SR, Jenq RR, Hanash AM, Jacobsohn D, Santomasso BD, Jain S, Ogawa Y, Steven P, Luo ZK, Dietrich-Ntoukas T, Saban D, Bilic E, Penack O, Griffith LM, Cowden M, Martin PJ, Greinix HT, Sarantopoulos S, Socie G, Blazar BR, Pidala J, Kitko CL, Couriel DR, Cutler C, Schultz KR, Pavletic SZ, Lee SJ, Paczesny S. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. Transplant Cell Ther. 2021 Oct;27(10):817-835. doi: 10.1016/j.jtct.2021.06.001. Epub 2021 Jun 10. PubMed PMID: 34217703; PubMed Central PMCID: PMC8478861.

Sheshadri A, Huang H, Bashoura L, Alousi A, Alkhunaizi M, Sharifi H, Hsu J. Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease. Blood Adv. 2022 Sep 13;6(17):4984-4986. doi: 10.1182/bloodadvances.2022008201. PMID: 35793452; PMCID: PMC9631650.

Cheng GS, Crothers K, Aliberti S, Bergeron A, Boeckh M, Chien JW, Cilloniz C, Cohen K, Dean N, Dela Cruz CS, Dickson RP, Greninger AL, Hage CA, Hohl TM, Holland SM, Jones BE, Keane J, Metersky M, Miller R, Puel A, Ramirez J, Restrepo MI, Sheshadri A, Staitieh B, Tarrand J, Winthrop KL, Wunderink RG, Evans SE. Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2023 Mar;20(3):341-353. doi: 10.1513/AnnalsATS.202212-1019ST. PubMed PMID: 36856712; PubMed Central PMCID: PMC9993146.

Ostrin E, Rider N, Alousi A, Irajizad E, Li L, Peng Q, Kim S, Bashoura L, Arain M, Noor L, Patel N, Mehta R, Popat U, Hosing C, Jeng R, Rondon G, Hanash S, Paczesny S, Shpall E, Champlin R, Dickey B, Sheshadri A.  A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept. Immunohorizons. 2023 Jun 1;7(6):421-430. doi: 10.4049/immunohorizons.2300031. PMID: 37289498; PMCID: PMC10491477. 

Alkhunaizi M, José R, Sheshadri A. Pretransplant Pulmonary Evaluation. In: Soubani, A.O. (eds) Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation. Springer, Cham. June 15, 2023: pp 63-79 https://doi.org/10.1007/978-3-031-28797-8_4. 

Cheng G-S. Pulmonary Function and Pretransplant Evaluation of the Hematopoietic Cell Transplant Candidate. Clin Chest Med. 2017;38(2):307–16. doi: 10.1016/j.ccm.2016.12.014. PMID: 28477641.

Mehta R, Sheshadri A, Alousi AM. An Overview of Graft-Versus-Host Disease. In: Soubani, A.O. (eds) Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation. Springer, Cham. June 15, 2023: pp 17-44. https://doi.org/10.1007/978-3-031-28797-8_2. 

Sheshadri A, Sacks N, Healey B, Raza S, Boerner G, Huang H. Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation. Clin Ther. 2022 May;44(5):755-765.e6. doi: 10.1016/j.clinthera.2022.03.011. Epub 2022 May 2. PMID: 35513911. 

Sheshadri A, Huang H, Bashoura L, Alousi A, Alkhunaizi M, Sharifi H, Hsu J. Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease. Blood Adv. 2022 Sep 13;6(17):4984-4986. doi: 10.1182/bloodadvances.2022008201. Comment. PMID: 35793452; PMCID: PMC9631650. 

Alkhunaizi M, Patel B, Bueno L, Bhan N, Ahmed T, Arain M, Saliba R, Rondon G, Dickey B, Bashoura L, Ost D, Li L, Wang S, Shpall E, Champlin RE, Mehta R, Popat UR, Hosing C, Alousi AM, Sheshadri A. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation. Transplant Cell Ther. 2023 Mar;29(3):204.e1-204.e7. doi: 10.1016/j.jtct.2022.12.001. Epub 2022 Dec 9. PMID: 36503180; PMCID: PMC9992123. 

Sheshadri A, Makhoon S, Alousi AM, Bashoura L, Andrade R, Miller CJ, Stolar KR, Arain MH, Noor L, Balagani A, Jain A, Blanco D, Ortiz A, Taylor MS, Stenzler A, Mehta R, Popat UR, Hosing C, Ost DE, Champlin RE, Dickey BF, Peterson SK. Home-Based Spirometry Telemonitoring After Allogeneic Hematopoietic Cell Transplantation: Mixed Methods Evaluation of Acceptability and Usability. JMIR Form Res. 2022 Feb 7;6(2):e29393. doi: 10.2196/29393. PMID: 35129455; PMCID: PMC8861865. 

Sacks NC, Healey BE, Raza S, Cyr PL, Boerner G, Sheshadri A. The Economic Burden of NIPC and BOS Following Allogeneic HSCT in Patients with Commercial Insurance in the United States. Blood Adv. 2022 Mar 8;6(5):1566-1576. doi: 10.1182/bloodadvances.2021004364. PMID: 34807973; PMCID: PMC8905687. 

Jose RJ, Dickey BF, Sheshadri A. Airway Disease in Hematologic Malignancies. Expert Rev Respir Med. 2022 Mar;16(3):303-313. doi: 10.1080/17476348.2022.2043746. Epub 2022 Feb 21. Review.  PMID: 35176948; PMCID: PMC9067103. 

Sheshadri A, Saliba R, Patel B, Ahmed T, Bueno LC, Arain MH, Mehta R, Popat UR, Hosing CM, Rondon G, Bashoura L, Dickey BF, Champlin RE, Alousi AM. Azithromycin May Increase Hematologic Relapse Rates in Matched Unrelated Donor Hematopoietic Cell Transplant Recipients Who Receive Anti-Thymocyte Globulin, But Not in Most Other Recipients. Bone Marrow Transplant. 2021 Mar;56(3):745-748. doi: 10.1038/s41409-020-01073-0. Epub 2020 Oct 2. PMID: 33009515; PMCID: PMC7987872. 

Sheshadri A. Quantitative Lung Imaging in Hematopoietic Cell Transplant Recipients: A Window Into the Physiology of Bronchiolitis Obliterans. Chest. 2020 Sep;158(3):852-853. doi: 10.1016/j.chest.2020.04.012. Editorial. PMID: 32892879. 

Sheshadri A, Chemaly RF, Alousi AM, Shah PK, Rondon G, Bashoura L, Kmeid J, Azzi J, Blanco DW, Kaous M, Dickey BF, Champlin RE, Shah DP.  Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant. 2019 Apr;25(4):800-809. doi: 10.1016/j.bbmt.2018.11.022. Epub 2018 Dec 3. PMID: 30521974; PMCID: PMC6453743.